Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Apr;52(4):294–300. doi: 10.1136/jcp.52.4.294

Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.

J Thiele 1, T K Zirbes 1, H M Kvasnicka 1, R Fischer 1
PMCID: PMC501336  PMID: 10474523

Abstract

AIMS: To provide practical guidelines for the differentiation between benign and malignant focal lymphoid aggregates (lymphoid nodules) in routinely referred bone marrow trephine biopsies, using a synoptic approach including clinical data and histological workup. METHODS: For easy identification of very small lymphoid infiltrates the chloroacetate esterase stain was applied as a screening procedure. This allowed the identification of 491 formalin fixed, paraffin wax embedded specimens with one or more lymphoid nodules. Examination of lymphoid infiltrates included such variables as histotopography, demarcation, cytology, reticulin fibres, and immunohistochemistry with a set of monoclonal antibodies (CD20, CD45R, CD45R0, CD3, CD43). Evaluation of clinical and morphological data was carried out independently. In case of malignant lymphomas, a correlation with corresponding lymph node findings was made. RESULTS: 352 patients had benign focal lymphoid aggregates usually associated with systemic autoimmune diseases, chronic myeloproliferative disorders, toxic myelopathy, and viral infections. Discrete nodular infiltrates of (small cell) malignant lymphomas (n = 93) simulating benign hyperplasia were found in chronic lymphocytic leukaemia, germinal centre cell lymphomas (CB-CC), and lymphoplasmacytic/cytoid lymphomas (LPI). In addition to immunoreactivity, certain histological variables proved distinctive. These were: (1) histotopography, that is, localisation of the lymphoid aggregates within the bone marrow space; (2) relation to the surrounding tissue: margination or interstitial spillage of lymphoid cells; and (3) increase in reticulin fibres. CONCLUSIONS: A combined diagnostic procedure identifying several distinctive features, in particular histotopography and immunohistochemistry, provides a most promising way of discriminating reactive from neoplastic lymphoid nodules in the bone marrow.

Full text

PDF
296

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartl R., Frisch B., Burkhardt R., Huhn D., Pappenberger R. Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol. 1982 Jul;51(3):345–360. doi: 10.1111/j.1365-2141.1982.tb02790.x. [DOI] [PubMed] [Google Scholar]
  2. Bartl R., Frisch B., Burkhardt R., Jäger K., Pappenberger R., Hoffmann-Fezer G. Lymphoproliferations in the bone marrow: identification and evolution, classification and staging. J Clin Pathol. 1984 Mar;37(3):233–254. doi: 10.1136/jcp.37.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartl R., Frisch B., Burkhardt R., Kettner G., Mahl G., Fateh-Moghadam A., Sund M. Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin's): correlation with clinical factors for diagnosis, prognosis, classification and staging. Br J Haematol. 1982 Aug;51(4):511–530. doi: 10.1111/j.1365-2141.1982.tb02815.x. [DOI] [PubMed] [Google Scholar]
  4. Bartl R., Frisch B., Wilmanns W. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur J Haematol. 1993 Jan;50(1):41–52. doi: 10.1111/j.1600-0609.1993.tb00073.x. [DOI] [PubMed] [Google Scholar]
  5. Bartl R., Hansmann M. L., Frisch B., Burkhardt R. Comparative histology of malignant lymphomas in lymph node and bone marrow. Br J Haematol. 1988 Jun;69(2):229–237. doi: 10.1111/j.1365-2141.1988.tb07627.x. [DOI] [PubMed] [Google Scholar]
  6. Ben-Ezra J. M., King B. E., Harris A. C., Todd W. M., Kornstein M. J. Staining for Bcl-2 protein helps to distinguish benign from malignant lymphoid aggregates in bone marrow biopsies. Mod Pathol. 1994 Jun;7(5):560–564. [PubMed] [Google Scholar]
  7. Bennett J. M., Cain K. C., Glick J. H., Johnson G. J., Ezdinli E., O'Connell M. J. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience. J Clin Oncol. 1986 Oct;4(10):1462–1469. doi: 10.1200/JCO.1986.4.10.1462. [DOI] [PubMed] [Google Scholar]
  8. Cervantes F., Pereira A., Marti J. M., Feliu E., Rozman C. Bone marrow lymphoid nodules in myeloproliferative disorders: association with the nonmyelosclerotic phases of idiopathic myelofibrosis and immunological significance. Br J Haematol. 1988 Nov;70(3):279–282. doi: 10.1111/j.1365-2141.1988.tb02482.x. [DOI] [PubMed] [Google Scholar]
  9. Conlan M. G., Bast M., Armitage J. O., Weisenburger D. D. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. J Clin Oncol. 1990 Jul;8(7):1163–1172. doi: 10.1200/JCO.1990.8.7.1163. [DOI] [PubMed] [Google Scholar]
  10. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  11. Erber W. N. Human leucocyte differentiation antigens: review of the CD nomenclature. Pathology. 1990 Apr;22(2):61–69. doi: 10.3109/00313029009063782. [DOI] [PubMed] [Google Scholar]
  12. Fakan F., Skálová A., Kuntscherová J. Expression of bcl-2 protein in distinguishing benign from malignant lymphoid aggregates in bone marrow biopsies. Gen Diagn Pathol. 1996 May;141(5-6):359–363. [PubMed] [Google Scholar]
  13. Faulkner-Jones B. E., Howie A. J., Boughton B. J., Franklin I. M. Lymphoid aggregates in bone marrow: study of eventual outcome. J Clin Pathol. 1988 Jul;41(7):768–775. doi: 10.1136/jcp.41.7.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Foucar K., McKenna R. W., Frizzera G., Brunning R. D. Bone marrow and blood involvement by lymphoma in relationship to the Lukes--Collins classification. Cancer. 1982 Mar 1;49(5):888–897. doi: 10.1002/1097-0142(19820301)49:5<888::aid-cncr2820490512>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  15. Franco V., Florena A. M., Aragona F., Campesi G. Immunohistochemical evaluation of bone marrow lymphoid nodules in chronic myeloproliferative disorders. Virchows Arch A Pathol Anat Histopathol. 1991;419(4):261–266. doi: 10.1007/BF01606516. [DOI] [PubMed] [Google Scholar]
  16. Frisch B., Bartl R. Histologic classification and staging of chronic lymphocytic leukemia. A retrospective and prospective study of 503 cases. Acta Haematol. 1988;79(3):140–152. doi: 10.1159/000205747. [DOI] [PubMed] [Google Scholar]
  17. Han T., Barcos M., Emrich L., Ozer H., Gajera R., Gomez G. A., Reese P. A., Minowada J., Bloom M. L., Sadamori N. Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data. J Clin Oncol. 1984 Jun;2(6):562–570. doi: 10.1200/JCO.1984.2.6.562. [DOI] [PubMed] [Google Scholar]
  18. Harris C. E., Biggs J. C., Concannon A. J., Dodds A. J. Peripheral blood and bone marrow findings in patients with acquired immune deficiency syndrome. Pathology. 1990 Oct;22(4):206–211. doi: 10.3109/00313029009086664. [DOI] [PubMed] [Google Scholar]
  19. Karcher D. S., Frost A. R. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. Am J Clin Pathol. 1991 Jan;95(1):63–71. doi: 10.1093/ajcp/95.1.63. [DOI] [PubMed] [Google Scholar]
  20. Kluin P. M., van Krieken J. H., Kleiverda K., Kluin-Nelemans H. C. Discordant morphologic characteristics of B-cell lymphomas in bone marrow and lymph node biopsies. Am J Clin Pathol. 1990 Jul;94(1):59–66. doi: 10.1093/ajcp/94.1.59. [DOI] [PubMed] [Google Scholar]
  21. Kronland R., Grogan T., Spier C., Wirt D., Rangel C., Richter L., Durie B., Greenberg B., Miller T., Jones S. Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow. Hum Pathol. 1985 Dec;16(12):1247–1254. doi: 10.1016/s0046-8177(85)80038-1. [DOI] [PubMed] [Google Scholar]
  22. Lambertenghi-Deliliers G., Annaloro C., Soligo D., Oriani A., Pozzoli E., Quirici N., Luksch R., Polli E. E. Incidence and histological features of bone marrow involvement in malignant lymphomas. Ann Hematol. 1992 Aug;65(2):61–65. doi: 10.1007/BF01698130. [DOI] [PubMed] [Google Scholar]
  23. Manoharan A., Catovsky D., Clein P., Traub N. E., Costello C., O'Brien M., Boralessa H., Galton D. A. Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders: a report of four cases. Br J Haematol. 1981 May;48(1):111–116. doi: 10.1111/j.1365-2141.1981.00111.x. [DOI] [PubMed] [Google Scholar]
  24. McKenna R. W., Hernandez J. A. Bone marrow in malignant lymphoma. Hematol Oncol Clin North Am. 1988 Dec;2(4):617–635. [PubMed] [Google Scholar]
  25. Montserrat E., Rozman C. Bone marrow biopsy in chronic lymphocytic leukemia: a review of its prognostic importance. Blood Cells. 1987;12(2):315–326. [PubMed] [Google Scholar]
  26. Navone R., Valpreda M., Pich A. Lymphoid nodules and nodular lymphoid hyperplasia in bone marrow biopsies. Acta Haematol. 1985;74(1):19–22. doi: 10.1159/000206157. [DOI] [PubMed] [Google Scholar]
  27. Pangalis G. A., Roussou P. A., Kittas C., Kokkinou S., Fessas P. B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit. Cancer. 1987 Feb 15;59(4):767–771. doi: 10.1002/1097-0142(19870215)59:4<767::aid-cncr2820590417>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  28. Pileri S. A., Roncador G., Ceccarelli C., Piccioli M., Sabattini E., Briskomatis A., Santini D., Leone O., Piccaluga P. P., Leoncini L. Immunohistochemistry of bone-marrow biopsy. Leuk Lymphoma. 1997 Dec;26 (Suppl 1):69–75. doi: 10.3109/10428199709058602. [DOI] [PubMed] [Google Scholar]
  29. Pizzolo G., Chilosi M., Cetto G. L., Fiore-Donati L., Janossy G. Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders. Br J Haematol. 1982 Jan;50(1):95–100. doi: 10.1111/j.1365-2141.1982.tb01894.x. [DOI] [PubMed] [Google Scholar]
  30. Rozman C., Montserrat E., Rodríguez-Fernández J. M., Ayats R., Vallespí T., Parody R., Ríos A., Prados D., Morey M., Gomis F. Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood. 1984 Sep;64(3):642–648. [PubMed] [Google Scholar]
  31. Rywlin A. M., Ortega R. S., Dominguez C. J. Lymphoid nodules of bone marrow: normal and abnormal. Blood. 1974 Mar;43(3):389–400. [PubMed] [Google Scholar]
  32. Salisbury J. R., Deverell M. H., Cookson M. J. Three-dimensional reconstruction of benign lymphoid aggregates in bone marrow trephines. J Pathol. 1996 Apr;178(4):447–450. doi: 10.1002/(SICI)1096-9896(199604)178:4<447::AID-PATH489>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  33. Schmid C., Isaacson P. G. Bone marrow trephine biopsy in lymphoproliferative disease. J Clin Pathol. 1992 Sep;45(9):745–750. doi: 10.1136/jcp.45.9.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stansfeld A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelényi G., Sundstrom C., Lennert K., van Unnik J. A., Mioduszewska O. Updated Kiel classification for lymphomas. Lancet. 1988 Feb 6;1(8580):292–293. doi: 10.1016/s0140-6736(88)90367-4. [DOI] [PubMed] [Google Scholar]
  35. Thaler J., Dietze O., Denz H., Demuth R., Nachbaur D., Stauder R., Huber H. Bone marrow diagnosis in lymphoproliferative disorders: comparison of results obtained from conventional histomorphology and immunohistology. Histopathology. 1991 Jun;18(6):495–504. doi: 10.1111/j.1365-2559.1991.tb01475.x. [DOI] [PubMed] [Google Scholar]
  36. Thiele J., Arenz B., Klein H., Vierbuchen M., Zankovich R., Fischer R. Differentiation of plasma cell infiltrates in the bone marrow. A clinicopathological study on 80 patients including immunohistochemistry and morphometry. Virchows Arch A Pathol Anat Histopathol. 1988;412(6):553–562. doi: 10.1007/BF00844291. [DOI] [PubMed] [Google Scholar]
  37. Thiele J., Langohr J., Skorupka M., Fischer R. Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy)--a morphometric evaluation before and after therapy. Virchows Arch A Pathol Anat Histopathol. 1990;417(6):485–492. doi: 10.1007/BF01625728. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES